LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

33.16 -2.36

Buy Sell

Overview

Share price change

24h

Current

Min

32.7

Max

33.99

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	10.722 106.172
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+35.33% upside

Market Stats
By TradingEconomics
Market Cap	270M 2B
Previous open	35.52
Previous close	33.16

News Sentiment

By Acuity

34%

66%

102 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 lis 2025, 23:36 UTC

Hot Stocks

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 lis 2025, 22:13 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 lis 2025, 21:55 UTC

Major Market Movers

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 lis 2025, 21:43 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 lis 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19 lis 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 lis 2025, 23:47 UTC

Earnings

Lenovo Group 2Q EPS $2.52 >0992.HK

19 lis 2025, 23:46 UTC

Earnings

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 lis 2025, 23:45 UTC

Earnings

Lenovo Group 2Q Rev $20.5B >0992.HK

19 lis 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 lis 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19 lis 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 lis 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 lis 2025, 23:40 UTC

Earnings

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 lis 2025, 22:55 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 lis 2025, 22:41 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 lis 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 lis 2025, 22:30 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 lis 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 lis 2025, 22:27 UTC

Acquisitions, Mergers, Takeovers

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 lis 2025, 22:08 UTC

Earnings

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 lis 2025, 22:00 UTC

Earnings

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 lis 2025, 21:58 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 lis 2025, 21:52 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 lis 2025, 21:50 UTC

Market Talk

Earnings

Tech, Media & Telecom Roundup: Market Talk

19 lis 2025, 21:49 UTC

Market Talk

Earnings

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 lis 2025, 21:38 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 lis 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B

19 lis 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 lis 2025, 21:24 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

35.33% upside

12 Months Forecast

Average 46 USD 35.33%

High 62 USD

Low 32 USD

Based on 10 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

102 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.